Evan Dale Abel

Evan Dale Abel, a Professor at the David Geffen School of Medicine at the University of California, Los Angeles, is a distinguished endocrinologist specializing in metabolic regulation in the cardiovascular system, mitochondrial biology, and diabetes-related complications. His research has significantly advanced understanding of mitochondrial dysfunction in heart failure and atherothrombosis in diabetes.

Education:

• MB.BS, University of the West Indies (first recipient with distinction)
• DPhil in Physiology, Oxford University (Rhodes Scholar, 1991)

Training: Internal Medicine at Northwestern University; Endocrinology at Harvard University.

Research Interests: The Abel laboratory investigates the role of mitochondrial dysfunction and aberrant insulin signaling in diabetes-associated cardiovascular pathologies. Recent work includes:

• Mechanisms of inter-organ crosstalk via mitochondrial pathways
• Metabolic signals regulating cardiac hypertrophy
• Links between diabetes, insulin resistance, and atherothrombosis

Scientific Awards:

• Innovator Award, ISHR
• Arnold Katz Award, Sarnoff Foundation
• Gerald D. Aurbach Award, Endocrine Society

Leadership & Memberships: Elected member of the National Academy of Medicine (2022), American Association of Physicians, American Society for Clinical Investigation, and American Clinical and Climatological Association. Former President of the Endocrine Society and the Association of Professors of Medicine.